CY1118847T1 - Συνθεση που βελτιωνει την αποδοση και χρηση αυτης - Google Patents

Συνθεση που βελτιωνει την αποδοση και χρηση αυτης

Info

Publication number
CY1118847T1
CY1118847T1 CY20171100294T CY171100294T CY1118847T1 CY 1118847 T1 CY1118847 T1 CY 1118847T1 CY 20171100294 T CY20171100294 T CY 20171100294T CY 171100294 T CY171100294 T CY 171100294T CY 1118847 T1 CY1118847 T1 CY 1118847T1
Authority
CY
Cyprus
Prior art keywords
performance
composition
improve
mammal
solid
Prior art date
Application number
CY20171100294T
Other languages
English (en)
Inventor
Jon Lundberg
Eddie Weitzberg
Original Assignee
Heartbeet Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39721497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118847(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Heartbeet Ltd. filed Critical Heartbeet Ltd.
Publication of CY1118847T1 publication Critical patent/CY1118847T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D9/00—Nitrates of sodium, potassium or alkali metals in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η απόδοση ενός θηλαστικού, η οποία εκδηλώνεται ως μειωμένη πρόσληψη οξυγόνου (VO2) κατά τη διάρκεια της φυσικής άσκησης, μπορεί να βελτιωθεί με χορήγηση στο εν λόγω θηλαστικό μιας μη-τοξικής ποσότητας νιτρικού και / ή νιτρώδους. Υγρά, ημι-στερεά και στερεά σνακ και φαγητά και συμπληρώματα διατροφής, όπως αθλητικά ποτά, βρίσκονται προς διάθεση.
CY20171100294T 2007-02-26 2017-03-07 Συνθεση που βελτιωνει την αποδοση και χρηση αυτης CY1118847T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700520 2007-02-26
SE0700729 2007-03-22
PCT/SE2008/050211 WO2008105730A1 (en) 2007-02-26 2008-02-26 Performance enhancing composition and use thereof

Publications (1)

Publication Number Publication Date
CY1118847T1 true CY1118847T1 (el) 2018-01-10

Family

ID=39721497

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100294T CY1118847T1 (el) 2007-02-26 2017-03-07 Συνθεση που βελτιωνει την αποδοση και χρηση αυτης

Country Status (12)

Country Link
US (2) US9180140B2 (el)
EP (2) EP2124638B1 (el)
JP (1) JP2010519335A (el)
CA (1) CA2678093C (el)
CY (1) CY1118847T1 (el)
DK (1) DK2124638T3 (el)
ES (1) ES2618655T3 (el)
HR (1) HRP20170355T1 (el)
HU (1) HUE031982T2 (el)
PL (1) PL2124638T3 (el)
PT (1) PT2124638T (el)
WO (1) WO2008105730A1 (el)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010519336A (ja) 2007-02-26 2010-06-03 ルンドベルク，ヨン 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US10821132B2 (en) * 2007-02-26 2020-11-03 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
US10835555B2 (en) * 2007-02-26 2020-11-17 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
AU2008322437B2 (en) 2007-11-15 2013-11-07 Louisiana State University Use of nitrite salts in chronic ischemia
US9241999B2 (en) * 2009-06-15 2016-01-26 Board Of Regents Of The University Of Texas System Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
DE102009041425B4 (de) * 2009-08-13 2017-08-31 Aeroscan Gmbh Verfahren zur Steuerung eines Spiroergometriesystems und Spiroergometriesystem
JP5758904B2 (ja) 2009-10-14 2015-08-05 セラバスク インコーポレーテッド ニトライトの医薬製剤及びそれらの使用
HUE032165T2 (en) 2011-04-13 2017-09-28 Thermolife Int Llc Methods of using N-actyl-beta-alanine
EP2675291B1 (en) * 2012-05-07 2015-10-07 Premier Nutrition Corporation Puree compositions having specific carbohydrate ratios and methods for using same
ES2741146T3 (es) 2013-02-20 2020-02-10 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Formulaciones farmacéuticas de nitrio y sus usos
CA2902965C (en) 2013-02-28 2023-08-29 Aires Pharmaceuticals, Inc. Inorganic nitrite to improve cardiopulmonary hemodynamics
CA2915396A1 (en) * 2013-06-13 2014-12-18 The Hershey Company Food compositions that enhance nitric oxide mediated signalling
SG10201709264XA (en) 2013-06-28 2018-01-30 Benny Antony A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same
US11338005B2 (en) 2013-06-28 2022-05-24 Arjuna Natural Private Limited Medicinal composition of amaranth origin for cardiovascular treatment
US20160095341A1 (en) * 2014-06-13 2016-04-07 The Hershey Company Food compositions that enhance nitric oxide mediated signalling
JP2016032808A (ja) * 2014-07-30 2016-03-10 株式会社サンダーアーク 機能性飲料水及びその製造方法
ES2948678T3 (es) 2015-05-06 2023-09-15 Yara Int Asa Uso de nitrato para el tratamiento del síndrome de disgalactia posparto de mamíferos monogástricos
EP4233877A3 (en) * 2015-05-27 2023-10-25 VDF Futureceuticals, Inc. Compositions and methods for increasing athletic performance
US11241406B2 (en) 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels
US10420514B2 (en) 2016-02-25 2019-09-24 Samsung Electronics Co., Ltd. Detection of chronotropic incompetence
US10172517B2 (en) 2016-02-25 2019-01-08 Samsung Electronics Co., Ltd Image-analysis for assessing heart failure
US11164596B2 (en) 2016-02-25 2021-11-02 Samsung Electronics Co., Ltd. Sensor assisted evaluation of health and rehabilitation
US10362998B2 (en) 2016-02-25 2019-07-30 Samsung Electronics Co., Ltd. Sensor-based detection of changes in health and ventilation threshold
WO2017180501A1 (en) 2016-04-11 2017-10-19 President And Fellows Of Harvard College Probiotic formulations for improving athletic performance
US11247902B2 (en) 2016-06-06 2022-02-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Pharmaceutical formulations of nitrite and uses thereof
JP6971495B2 (ja) * 2017-03-23 2021-11-24 ミッション ソルト インコーポレイテッド ビートルート含有組成物
GB202004927D0 (en) 2020-04-03 2020-05-20 Sis Science In Sport Ltd Compositions
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CN112772789B (zh) * 2020-12-31 2023-05-09 内江师范学院 石榴皮饲料用功能添加剂、制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB962209A (en) * 1962-04-19 1964-07-01 Upjohn Co Multi-vitamin compositions containing fluorides
US4868179A (en) 1987-04-22 1989-09-19 Cohn Jay N Method of reducing mortality associated with congestive heart failure using hydralazine and isosorbide dinitrate
CA2066951A1 (en) * 1991-04-26 1992-10-27 Kou Moriyama Edible composition
US5476847A (en) 1994-06-29 1995-12-19 Schering Corporation Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
US20050036996A1 (en) * 1996-12-24 2005-02-17 Edmond Roussel Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal
JP2001513078A (ja) 1996-12-30 2001-08-28 バテル・メモリアル・インスティテュート 吸入により新生物を治療する製剤とその方法
US6117872A (en) * 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
WO2000018392A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase: antagonists and inhibitors
DE19913437B4 (de) * 1999-03-25 2009-05-14 Karl Müller GmbH & Co. Verwendung einer Umrötungsmischung
WO2001017528A1 (en) * 1999-09-08 2001-03-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
WO2003027046A2 (en) * 2000-11-02 2003-04-03 The Lubrizol Corporation Stabilized energetic water in oil emulsion composition
KR20020057695A (ko) * 2001-01-03 2002-07-12 류경열 야채 종합 비타민 강정제 제조방법
US20030036565A1 (en) * 2001-06-22 2003-02-20 Wisconsin Alumni Research Foundation Cancer chemopreventive agents
SE0203817D0 (sv) 2002-12-20 2002-12-20 Jon Lundberg New composition
KR100492083B1 (ko) * 2003-02-22 2005-06-01 삼성전자주식회사 화상형성장치의 급지 카세트
JP4100224B2 (ja) * 2003-04-07 2008-06-11 大正製薬株式会社 飲料組成物
CA2536827C (en) 2003-07-09 2014-09-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2005097085A1 (en) * 2004-04-08 2005-10-20 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US20050266018A1 (en) * 2004-05-27 2005-12-01 Boreyko Benson K Nutraceutical compositions with mangosteen
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006110601A2 (en) 2005-04-07 2006-10-19 Nitromed, Inc. The genetic risk assessment in heart failure: impact of the genetic variation of nos3
GB0522566D0 (en) 2005-11-04 2005-12-14 Novartis Ag Organic compounds
JP2010519336A (ja) * 2007-02-26 2010-06-03 ルンドベルク，ヨン 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs

Also Published As

Publication number Publication date
EP3159000A1 (en) 2017-04-26
US10555968B2 (en) 2020-02-11
DK2124638T3 (en) 2017-03-20
PL2124638T3 (pl) 2017-07-31
JP2010519335A (ja) 2010-06-03
US20150352147A1 (en) 2015-12-10
US9180140B2 (en) 2015-11-10
EP2124638A1 (en) 2009-12-02
EP2124638A4 (en) 2014-04-02
PT2124638T (pt) 2017-03-13
EP2124638B1 (en) 2016-12-07
HUE031982T2 (en) 2017-08-28
ES2618655T3 (es) 2017-06-21
WO2008105730A1 (en) 2008-09-04
CA2678093C (en) 2017-10-24
US20100047344A1 (en) 2010-02-25
HRP20170355T1 (hr) 2017-05-19
CA2678093A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
CY1118847T1 (el) Συνθεση που βελτιωνει την αποδοση και χρηση αυτης
NO2019004I1 (no) patisiran: dekket gjennom sekvensene i kravene 1, 8 og 9 (se særlig krav 8 (b) og (c) i patentet. Det vises også til følgebrevet til søknaden.
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1118611T1 (el) Συνδυασμοι που περιεχουν παραγωγα της 6-βενζυλο-φαινυλο-2-θειοτετραϋδροπυραν-3,4,5-τριολης ως αναστολεις των συμμεταφορεων 1 και 2 νατριου-γλυκοζης για να χρησιμοποιηθουν σε διαβητικους ασθενεις
UY33647A (es) ?agentes de unión a cd33?.
CY1118725T1 (el) Σταθερη ενωση σιδηρου-ολιγοσακχαριτη
EA201491697A1 (ru) Составы агонистов гуанилатциклазы с и способы применения
CY1113543T1 (el) Μεθοδοι χορηγησης τετραϋδροβιοπτερινης, οι σχετικες ενωσεις και οι μεθοδοι μετρησης
CO6410314A2 (es) Proteínas de unión a il-17
IL195030A (en) IV dpp inhibitor assemblies
SV2010003673A (es) Compuestos heterociclicos novedosos y usos de los mismos
JP2013522425A5 (el)
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
ECSP10010106A (es) Trans-clomifeno para el síndrome metabólico
UA109122C2 (uk) Синергічна гербіцидна композиція, яка містить амінопіралід і 2,4-дихлорфеноксіоцтову кислоту
EA201200122A1 (ru) КОНЬЮГАТЫ ε-ПОЛИЛИЗИНА И ИХ ПРИМЕНЕНИЕ
AR061544A1 (es) Masa de adsorcion y procedimiento para eliminar co de corrientes de sustancias
CL2007002816A1 (es) Composicion oral sin sabor metalico que comprende una fuente de hierro seleccionada del grupo de polimaltosa de hierro y carbonil hierro, y/o citrato de cobre como fuente de cobre; composicion nutricional oral que la comprende; y su uso para equilibr
UY29250A1 (es) Agentes citotóxicos que comprenden nuevos taxanos modificados en c-2.-
ATE506053T1 (de) Zusammensetzung aus liponsäure-pellets
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
TW200726460A (en) Anti-fatigue composition
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
EA201490638A1 (ru) КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ РАКА C ПРИМЕНЕНИЕМ ИНГИБИТОРА PI3Kβ И ИНГИБИТОРА СИГНАЛЬНОГО ПУТИ MAPK, ВКЛЮЧАЯ MEK И RAF ИНГИБИТОРЫ
TR201909029T4 (tr) Rifaksimin alfa içeren saklanmaya yönelik kararlı bileşimler.